211 related articles for article (PubMed ID: 26200037)
1. Elevated Human Endothelial Cell-Specific Molecule-1 Level and Its Association With Coronary Artery Disease in Patients With Hypertension.
Xiong C; Zhao ZW; Chen ZY; Wu LZ; Luo YK; Hu FD; Lin CG; Chen LL
J Investig Med; 2015 Oct; 63(7):867-70. PubMed ID: 26200037
[TBL] [Abstract][Full Text] [Related]
2. Serum endocan levels are correlated with the presence and severity of coronary artery disease in patients with hypertension.
Wang XS; Yang W; Luo T; Wang JM; Jing YY
Genet Test Mol Biomarkers; 2015 Mar; 19(3):124-7. PubMed ID: 25588082
[TBL] [Abstract][Full Text] [Related]
3. Human Endothelial Cell-Specific Molecule-1 (Endocan) and Coronary Artery Disease and Microvascular Angina.
Çimen T; Efe TH; Akyel A; Sunman H; Algül E; Şahan HF; Erden G; Özdemir Ş; Alay EF; Doğan M; Yeter E
Angiology; 2016 Oct; 67(9):846-53. PubMed ID: 26744512
[TBL] [Abstract][Full Text] [Related]
4. Serum Endocan Level and the Severity of Coronary Artery Disease: A Pilot Study.
Kose M; Emet S; Akpinar TS; Kocaaga M; Cakmak R; Akarsu M; Yuruyen G; Arman Y; Tukek T
Angiology; 2015 Sep; 66(8):727-31. PubMed ID: 25168956
[TBL] [Abstract][Full Text] [Related]
5. Elevated endocan concentration is associated with coronary slow flow.
Ye MF; Zhao ZW; Luo YK; Dong XF; Yan YM
Scand J Clin Lab Invest; 2016 Sep; 76(5):345-8. PubMed ID: 27180882
[TBL] [Abstract][Full Text] [Related]
6. Plasma Endocan Levels in Patients With Isolated Coronary Artery Ectasia.
Turan T; Akyuz AR; Aykan AC; Kul S; Cirakoglu OF; Aslan AO; Gul I; Uçar U; Demir S; Celik S
Angiology; 2016 Nov; 67(10):932-936. PubMed ID: 26980772
[TBL] [Abstract][Full Text] [Related]
7. Serum endocan levels as a marker of disease activity in patients with Behçet disease.
Balta I; Balta S; Koryurek OM; Demirkol S; Mikhailidis DP; Celik T; Cakar M; Kucuk U; Eksioglu M; Kurt YG
J Am Acad Dermatol; 2014 Feb; 70(2):291-6. PubMed ID: 24176522
[TBL] [Abstract][Full Text] [Related]
8. [Can biomarkers help us to understand the pathogenesis of coronary slow flow? Endocan and omentin-I in slow coronary flow phenomenon].
Sığırcı S; Sarıkaya R; Keskin K; Yıldız SS; Pilten Güzel S; Çetinkal G; Önur İ; Kılıçkesmez KO
Turk Kardiyol Dern Ars; 2019 Jun; 47(4):251-257. PubMed ID: 31219439
[TBL] [Abstract][Full Text] [Related]
9. Perioperative kinetics of endocan in patients undergoing cardiac surgery with and without cardiopulmonary bypass.
Madhivathanan PR; Fletcher N; Gaze D; Thomson R; Chandrasekaran V; Al-Subaie N; Valencia O; Sharma V
Cytokine; 2016 Jul; 83():8-12. PubMed ID: 26999704
[TBL] [Abstract][Full Text] [Related]
10. The Relationship Between Serum Endocan Levels With the Presence of Slow Coronary Flow: A Cross-Sectional Study.
Kundi H; Gok M; Kiziltunc E; Topcuoglu C; Cetin M; Cicekcioglu H; Ugurlu B; Ulusoy FV
Clin Appl Thromb Hemost; 2017 Jul; 23(5):472-477. PubMed ID: 26607436
[TBL] [Abstract][Full Text] [Related]
11. Endocan--a novel inflammatory indicator in newly diagnosed patients with hypertension: a pilot study.
Balta S; Mikhailidis DP; Demirkol S; Ozturk C; Kurtoglu E; Demir M; Celik T; Turker T; Iyisoy A
Angiology; 2014 Oct; 65(9):773-7. PubMed ID: 24402320
[TBL] [Abstract][Full Text] [Related]
12. Endocan Levels and Coronary Collateral Circulation in Stable Angina Pectoris: A Pilot Study.
Gok M; Kundi H; Kiziltunc E; Topcuoglu C; Ornek E
Angiology; 2018 Jan; 69(1):43-48. PubMed ID: 28393589
[TBL] [Abstract][Full Text] [Related]
13. Endocan is markedly overexpressed in severe erectile dysfunction.
Akarsu M; Atalay HA; Canat L; Ozcan M; Arman Y; Aydın S; Cil E; Kutlu O; Tükek T
Andrologia; 2018 Apr; 50(3):. PubMed ID: 29057489
[TBL] [Abstract][Full Text] [Related]
14. Elevated endocan levels and its association with clinical severity in Stevens-Johnson Syndrome and toxic epidermal necrolysis.
Syed D; Iqbal O; Mosier M; Mitchell R; Hoppensteadt D; Bouchard C; Fareed J; Gamelli R
Int Angiol; 2015 Oct; 34(5):483-8. PubMed ID: 25394955
[TBL] [Abstract][Full Text] [Related]
15. Serum levels of endocan correlate with the presence and severity of pre-eclampsia.
Cakmak M; Yilmaz H; Bağlar E; Darcin T; Inan O; Aktas A; Celik HT; Ozdemir O; Atalay CR; Akcay A
Clin Exp Hypertens; 2016; 38(2):137-42. PubMed ID: 26418319
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of serum endothelial cell specific molecule-1 (endocan) levels as a biomarker in patients with pulmonary thromboembolism.
Güzel A; Duran L; Köksal N; Torun AC; Alaçam H; Ekiz BC; Murat N
Blood Coagul Fibrinolysis; 2014 Apr; 25(3):272-6. PubMed ID: 24509328
[TBL] [Abstract][Full Text] [Related]
17. Endocan: a novel biomarker associated with well-developed coronary collateral circulation in patients with stable angina and chronic total occlusion.
Emet S; Elitok A; Onur I; Kocaaga M; Bilge AK; Oflaz H; Umman B; Oncul A; Bugra Z; Adalet K; Mercanoglu F
J Thromb Thrombolysis; 2017 Jan; 43(1):60-67. PubMed ID: 27638814
[TBL] [Abstract][Full Text] [Related]
18. Endocan Levels and Endothelial Dysfunction in Patients With Sarcoidosis.
Aciksari G; Kavas M; Atici A; Kul S; Erman H; Yilmaz Y; Demircioglu K; Yalcinkaya E; Kanbay A; Caliskan M
Angiology; 2018 Nov; 69(10):878-883. PubMed ID: 29747515
[TBL] [Abstract][Full Text] [Related]
19. Endocan: A novel inflammatory indicator in cardiovascular disease?
Balta S; Mikhailidis DP; Demirkol S; Ozturk C; Celik T; Iyisoy A
Atherosclerosis; 2015 Nov; 243(1):339-43. PubMed ID: 26448266
[TBL] [Abstract][Full Text] [Related]
20. Serum endothelial cell specific molecule-1 (endocan) levels in patients with obstructive sleep apnea.
Bingol Z; Kose M; Pıhtılı A; Akpınar T; Tukek T; Kıyan E
Biomark Med; 2016; 10(2):177-84. PubMed ID: 26808694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
